Literature DB >> 4016580

Comparison of tissue reactions produced by Haemophilus pleuropneumoniae vaccines made with six different adjuvants in swine.

B E Straw, N J MacLachlan, W T Corbett, P B Carter, H M Schey.   

Abstract

Tissue damage caused by six different adjuvants incorporated in a Haemophilus pleuropneumoniae vaccine was compared in swine. The adjuvants compared were four mineral oil compounds, one peanut oil compound and aluminum hydroxide. Inoculations were given in the neck, quadriceps and semitendinosus muscles. The mineral oil adjuvants were highly irritant and caused extensive areas of granulomatous inflammation that were present at eight weeks after injection. The aluminum hydroxide produced smaller lesions that also persisted for eight weeks. Only the peanut oil adjuvant did not produce significant lesions at the site of injection. At two and four weeks, but not at eight weeks postinoculation, lesions in the quadriceps and semitendinosus muscles were approximately twice as extensive as those in the muscles of the neck.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4016580      PMCID: PMC1236138     

Source DB:  PubMed          Journal:  Can J Comp Med        ISSN: 0008-4050


  7 in total

1.  Preparation of inactivated oil-emulsion vaccines with avian viral or Mycoplasma antigens.

Authors:  H D Stone; M Brugh; S R Hopkins; H W Yoder; C W Beard
Journal:  Avian Dis       Date:  1978 Oct-Dec       Impact factor: 1.577

2.  Pleuropneumonia of swine caused by Haemophilus parahaemolyticus. Studies on the protection obtained by vaccination.

Authors:  R Nielsen
Journal:  Nord Vet Med       Date:  1976 Jul-Aug

3.  Antimicrobial sensitivity patterns of Haemophilus pleuropneumoniae isolates from pigs with pneumonia.

Authors:  M C Libal; C E Gates
Journal:  J Am Vet Med Assoc       Date:  1982-02-15       Impact factor: 1.936

4.  Comparison of three experimental inactivated oil-emulsion Newcastle disease vaccines.

Authors:  H D Stone; M Brugh; C W Beard
Journal:  Avian Dis       Date:  1981 Oct-Dec       Impact factor: 1.577

5.  Evaluation of the complement fixation test for the diagnosis of pleuropneumonia of swine caused by Haemophilus pleuropneumoniae.

Authors:  L H Lombin; S Rosendal; W R Mitchell
Journal:  Can J Comp Med       Date:  1982-04

6.  Vaccination against pleuropneumonia of pigs caused by Haemophilus pleuropneumoniae.

Authors:  S Rosendal; D S Carpenter; W R Mitchell; M R Wilson
Journal:  Can Vet J       Date:  1981-02       Impact factor: 1.008

7.  Adjuvant activity of a novel metabolizable lipid emulsion with inactivated viral vaccines.

Authors:  J A Reynolds; D G Harrington; C L Crabbs; C J Peters; N R Di Luzio
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

  7 in total
  10 in total

Review 1.  Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity.

Authors:  Nikolai Petrovsky
Journal:  Vaccine       Date:  2006-04-12       Impact factor: 3.641

Review 2.  Vaccine adjuvants: current challenges and future approaches.

Authors:  Jennifer H Wilson-Welder; Maria P Torres; Matt J Kipper; Surya K Mallapragada; Michael J Wannemuehler; Balaji Narasimhan
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

3.  Tissue reaction and immunity in swine immunized with Actinobacillus pleuropneumoniae vaccines.

Authors:  P J Willson; A Rossi-Campos; A A Potter
Journal:  Can J Vet Res       Date:  1995-10       Impact factor: 1.310

4.  Oral immunization of pigs with viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces pulmonary and systemic antibodies and protects against homologous aerosol challenge.

Authors:  A Hensel; N Stockhofe-Zurwieden; K Petzoldt; W Lubitz
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

5.  QS-21 enhances the early antibody response to oil adjuvant foot-and-mouth disease vaccine in cattle.

Authors:  Can Çokçalışkan; Tunçer Türkoğlu; Beyhan Sareyyüpoğlu; Ergün Uzunlu; Ayca Babak; Banu B Özbilge; Veli Gülyaz
Journal:  Clin Exp Vaccine Res       Date:  2016-07-29

Review 6.  Novel application of trimethyl chitosan as an adjuvant in vaccine delivery.

Authors:  Anshu Malik; Manish Gupta; Vatika Gupta; Himanshu Gogoi; Rakesh Bhatnagar
Journal:  Int J Nanomedicine       Date:  2018-11-23

Review 7.  Mechanistic bases for adverse vaccine reactions and vaccine failures.

Authors:  J A Roth
Journal:  Adv Vet Med       Date:  1999

Review 8.  Vaccines, adjuvants and autoimmunity.

Authors:  Luísa Eça Guimarães; Britain Baker; Carlo Perricone; Yehuda Shoenfeld
Journal:  Pharmacol Res       Date:  2015-08-12       Impact factor: 7.658

Review 9.  Vaccine delivery using nanoparticles.

Authors:  Anthony E Gregory; Richard Titball; Diane Williamson
Journal:  Front Cell Infect Microbiol       Date:  2013-03-25       Impact factor: 5.293

10.  Phytol-derived novel isoprenoid immunostimulants.

Authors:  Roshni Roy Chowdhury; Swapan K Ghosh
Journal:  Front Immunol       Date:  2012-03-22       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.